La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Context Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Context Therapeutics..

Context Therapeutics (NASDAQ:CNTX) Azioni, Catena delle Opzioni

CONTEXT THERAPEUTICS INC

Context Therapeutics

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Context Therapeutics Inc

WIIM

SHEL

Shraes of energy stocks are trading higher following Israel's strikes on Iran, which have raised oil prices amid potential disruptions in production.

Biotech

Large Cap

News

Health Care

Contracts

General

AstraZeneca Has Entered A Strategic Research Collaboration With Shijiazhuang City-based CSPC Pharmaceuticals For Oral Candidates To Treat Diseases Across Multiple Indications, CSPC Will Receive An Upfront Payment Of $110M, And Is Also Eligible To Receive Up To $1.62B In Potential Development Milestone Payments And Up To $3.6B In Sales Milestone Payments, Plus Potential Single-digit Sales Based Royalties.

JBLU

Shares of airline stocks are trading lower following Israel's strikes on Iran, which have raised fuel prices and could cloud the travel demand outlook.

GPUS

Hyperscale Data Projects $41M Annual Bitcoin Mining Run Rate Starting July 2025 With 19,200 Miners Across US Sites

BITF

CLSK

COIN

HIVE

MARA

MSTR

RIOT

Shares of crypto-linked stocks are trading lower following Israel's strikes on Iran, as risk-off sentiment pressures speculative assets.

$BTC

Bitcoin is trading lower following Israel's strikes on Iran, as the attacks could weigh on risk sentiment.

Shares of defense stocks are trading higher following Israel's strikes on Iran, which could lift demand outlook for military equipment.

Gold and silver are trading higher following Israel's attack on Iran, which has caused macro uncertainty and raised demand for safe-haven assets.

SPHL

Springview Singapore Says It Earns bizSAFE Level 4 Certification, Boosting Safety Standards And Market Opportunities

Oil is trading higher following Israel's strikes on Iran, which have caused supply uncertainty.

Enliven Therapeutics, Inc. (Enliven or the Company) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVN#NASDAQ">ELVN</a>), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has commenced an underwritten public offering of $200 million of shares of its common stock and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase shares of Enliven's common stock. In addition, Enliven intends to grant the underwriters a 30-day option to purchase up to an additional $30 million of shares of its common stock. All of the shares of common stock and pre-funded warrants are being offered by Enliven. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

ELVN

Enliven Therapeutics Launches $200M Public Offering With Option For $30M Upsize

Shares of defense stocks Rtx Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>), Lockheed Martin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) and General Dynamics Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) climbed 4.6%, 4.2% and 1.2%, respectively, during Friday&#8217;s pre-market trading session amid Israel&#8217;s intensifying military <a href="https://www.benzinga.com/markets/equities/25/06/45921212/us-stocks-likely-to-open-lower-as-israel-strikes-iran-geopolitical-risks-offers-upside-for-dollar-say-experts">operations in Lebanon and Iran.</a>
What Happened: Israel recently initiated an invasion of Lebanon and executed <a href="https://www.benzinga.com/news/politics/25/06/45919250/trump-administration-distances-us-from-israels-strikes-on-iran-we-are-not-involved-says-marco-rubio">leaders of Iran&#8217;s IRGC. </a>This act provoked Iran to launch extensive strikes against targets within Israel. Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), the largest arms manufacturer globally, produces the F-35 aircraft, which Israel employs in its regular bombardments of Gaza. 
RTX Corporation, formerly Raytheon, the second-largest arms manufacturer, provides Israel with &#8220;bunker buster&#8221; bombs, which are prohibited in densely populated areas.
Meanwhile, General Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>), another manufacturer of bunker busters, produces the BLU-109 bombs currently used by Israel.
SEE ALSO:&nbsp;<a href="https://benzinga.com/pressreleases/24/10/ab41310379/claritycheck-launches-innovative-reverse-lookup-tool-to-empower-users-against-digital-scams" target="_blank" rel="noreferrer noopener">ClarityCheck Launches Innovative Reverse Lookup Tool to Empower Users Against Digital Scams &#8211; Benzinga</a>
Why It Matters: The escalating tension in the Middle East has had a profound impact on global markets. Israel&#8217;s preemptive strike on Iran caused U.S. stock <a href="https://www.benzinga.com/markets/market-summary/25/06/45918802/middle-east-tensions-rattle-markets-us-stock-futures-slide-oil-jumps-8-gold-surges-above-3400-after-israel-strikes-iran">futures to slide</a>, oil prices to jump 8%, and gold to surge above $3,400.
Moreover, the Trump administration has distanced itself from Israel&#8217;s recent <a href="https://www.benzinga.com/news/politics/25/06/45919250/trump-administration-distances-us-from-israels-strikes-on-iran-we-are-not-involved-says-marco-rubio">military actions </a>against Iran. These strikes are expected to complicate President Donald Trump's efforts to negotiate a nuclear deal with Tehran.
Lastly, President Trump&#8217;s ambitious $175 billion plan <a href="https://www.benzinga.com/25/05/45548110/trumps-golden-dome-launches-new-era-for-defense-stocks-like-rtx-lockheed-martin-l3harris">to develop</a> a &#8220;Golden Dome&#8221; missile defense system announced in May is expected to usher in a new era for defense stocks like RTX, Lockheed Martin, and L3Harris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>).
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/tech/25/06/45897537/jamie-dimon-recalls-first-palantir-meeting-holy-christ-this-is-unbelievable-jpmorgan-now-has-600-ai-" target="_blank" rel="noreferrer noopener">Jamie Dimon Recalls First Palantir Meeting: &#8216;Holy Christ, This Is Unbelievable—&#8217; JPMorgan Now Has 600 AI Use Cases, $2 Billion Annual Investment On AI</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

Lockheed Martin, RTX, General Dynamics And Other Defense Stocks Rise In Friday Pre-Market: What's Going On?

Kennedy Wilson Buys 265-Unit Seattle Multifamily Asset For $173M, , Expands Investment Platform With Japanese Partners

Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent Phase 1 trials of approved &nbsp;

Enliven Therapeutics Announced Updated Data From Phase 1 ENABLE Clinical Trial Evaluating ELVN-001 In Patients With Chronic Myeloid Leukemia In An Oral Presentation At European Hematology Association 2025 Congress

Cloudflare Prices $1.75B Convertible Notes Due 2030 With Optional $250M Upsize, Eyes $1.72B Net Proceeds

ZKH Group Limited ("ZKH" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZKH#NYSE">ZKH</a>), a leading maintenance, repair and operations ("MRO") procurement service platform in China, today announced that its board of directors has authorized a new share repurchase program under which the Company may repurchase up to US$50 million worth of its shares (including American Depositary Shares) over the next 12 months, ending on June 13, 2026.
The share repurchases may be effected from time to time on the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions, and will be implemented in accordance with applicable rules and regulations. The Company expects to fund the repurchases out of its existing cash balance.

ZKH Group Launches $50M Share Buyback Program Through June 2026, Funded From Cash Reserves

The new licensing deals include major agreements with:
<ul>
<li>France TV for the nature documentary series Planet Insect</li>
<li>The WNET Group (U.S.), home to America's flagship PBS station in New York, for several Curiosity originals</li>
<li>Canal+ (France) for the critically acclaimed Titans: The Rise of Wall Street</li>
<li>Kanopy for a wide range of factual and educational titles</li>
<li>SRC/Explora (Canada) for Planet Insect</li>
<li>SRF (Switzerland) for the innovation-driven series Oops, I Changed the World</li>
<li>V-Me TV (U.S. Hispanic) for a wide range of factual programming</li>
<li>NATV (Korea) for the environmental science program Fateful Planet</li>
<li>Al Jazeera (MENA) for the bold food culture series Eat Me or Try Not To</li>
</ul>

CURI

Curiosity Inc. Expands Global Reach With New International Content Licensing Deals

The U.S. Food and Drug Administration (FDA) expanded approval of Moderna Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) respiratory syncytial virus vaccine to adults aged 18-59 at increased risk for disease.
What Happened: The FDA on Thursday approved broader use of Moderna&#8217;s mRESVIA vaccine for younger at-risk adults based on late-stage trial results, reported Reuters.
The mRNA-based shot showed significant immune responses in adults with underlying health conditions and maintained a favorable safety profile. The vaccine was previously limited to adults 60 and older, where it demonstrated 79% efficacy against RSV symptoms.
Health Secretary Robert F. Kennedy Jr. simultaneously <a href="https://www.benzinga.com/news/health-care/25/06/45898417/rfk-jr-appoints-vaccine-critics-to-cdc-vaccine-panel-after-firing-entire-advisory-committee-report">appointed eight new members to the CDC&#8217;s Advisory Committee</a> on Immunization Practices, including prominent mRNA vaccine critics Robert Malone and Retsef Levi.
The health secretary fired all 17 existing panel members, claiming the need to <a href="https://www.benzinga.com/news/health-care/25/06/45853393/robert-kennedy-jr-axes-entire-cdc-vaccine-panel-to-restore-public-trust-pfizer-moderna-other-biotech-stocks-drop-in-after-hours-trading">&#8220;re-establish public confidence in vaccine science.&#8221;</a> The committee provides crucial guidance on vaccine recommendations that influence insurance coverage and policy.
The CDC currently recommends RSV vaccines for adults 75 and older, plus those 60-74 at increased risk. The final CDC recommendation remains pending for the expanded age group before availability.
See Also: <a href="https://www.benzinga.com/markets/economic-data/25/06/45919422/trumps-one-big-beautiful-bill-is-the-largest-redistribution-from-poor-to-rich-in-american-history-says-economist-justin-wolfers-amid-tax-cuts-spending-s">Trump&#8217;s &#8216;One Big, Beautiful Bill&#8217; Is &#8216;The Largest Redistribution From Poor To Rich In American History,&#8217; Says Economist Justin Wolfers Amid Tax Cuts, Spending Slashes And Tariffs</a>
Why It Matters: William Blair analysts noted the <a href="https://www.benzinga.com/news/fda/25/06/45719840/modernas-new-covid-vaccine-secures-fda-clearance-for-seniors-at-risk-individuals">approval represents</a> &#8220;an incremental win for Moderna, especially considering HHS Secretary Robert F. Kennedy Jr.&#8217;s negative public opinion on mRNA COVID-19 vaccines.&#8221; However, they cautioned that approval alone won&#8217;t massively boost COVID vaccine sales, which depend primarily on overall vaccination market sentiment.
The advisory panel restructuring creates regulatory uncertainty for vaccine manufacturers. Kennedy&#8217;s broader policy changes include removing COVID vaccines from <a href="https://www.benzinga.com/government/regulations/25/05/45688464/rfk-jr-drops-covid-vaccine-recommendation-for-healthy-kids-but-experts-warn-of-major-risks">recommended schedules for healthy children and pregnant women</a>, plus terminating Moderna&#8217;s $600 million bird flu vaccine contract.
RSV hospitalizes 15,000-20,000 U.S. adults aged 50-59 annually. Competing vaccines from Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and GSK plc (LSE: GSK) also target similar demographics, intensifying market competition amid shifting federal oversight. Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45919626/coinbase-ceo-brian-armstrong-teases-crypto-credit-card-powered-by-american-express-bitcoin-cashbacks-offered-but-heres-the-catch">Coinbase CEO Brian Armstrong Teases Crypto Credit Card Powered By American Express—Bitcoin Cashbacks Offered, But Here&#8217;s The Catch</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Lutsenko_Oleksandr / Shutterstock.com

MRNA

FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up

U.S. stocks could open on a negative note on Friday after closing higher on Thursday. The decline comes amid Israel's pre-emptive strikes on Iran and retaliatory attacks from Iran, raising concerns about a further rise in tensions in the Middle East, impacting supply routes.
President Donald Trump once again threatened to impose unilateral tariffs within two weeks if the U.S.'s trade partners don't agree to a deal.
"At a certain point, we're just going to send letters out. And I think you understand that, saying this is the deal, you can take it or leave it," Trump told reporters at the John F. Kennedy Center for the Performing Arts.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-1.43%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.21%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-1.18%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.74%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Friday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) declined 1.23% to $596.34 and the Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) declined 1.49% to $525.73, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga Pro data</a>.
Cues From Last Session:
U.S. stocks ended Thursday on a mixed note, with the major indices in the green and the Russell 2000 ending in the red.
Crude oil surged to over $73 amid the Israel-Iran conflict.
Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) declined by nearly 5% after an Air India <a href="https://www.benzinga.com/markets/25/06/45911791/boeing-dreamliner-carrying-over-200-passengers-crashes-shortly-after-takeoff-near-indias-ahmedabad-b">Boeing 787-8 Dreamliner</a> carrying over 200 passengers crashed on Thursday near the Ahmedabad airport in India.
Most sectors on the S&amp;P 500 closed on a positive note, with only consumer discretionary, industrials, and communication services ending lower. Utilities, information technology and health care recorded the highest increase.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.24%</td>
<td>19,662.48</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.38%</td>
<td>6,045.26</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.24%</td>
<td>42,967.62</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.38%</td>
<td>2,140.09</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
While equities could bear the brunt of an increase in geopolitical risks and tensions in the Middle East due to the Israel-Iran conflict, analysts <a href="https://think.ing.com/articles/fx-daily-geopolitical-risk-storms-back-into-the-picture/">at</a> ING said that this could create some room for a brief rebound in the U.S. dollar.
"In other conditions, the DXY rally would likely be much larger than the roughly 0.75% rebound from the overnight lows we have seen so far, because the dollar would also benefit from the negative shock in equities and bonds," the research firm said.
The main concern, though, is a spike in oil prices. ING analysts highlighted that an energy price shock could force the Jerome Powell-led Federal Reserve to maintain its cautious stance on interest rate policy, which is something that has irked President Trump and others in his administration.
Upcoming Economic Data
Friday's major economic updates include:
<ul class="wp-block-list">
<li>The preliminary consumer sentiment data for June will be announced at 10:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>): The digital media company reported record revenue in Q2, beating Wall Street expectations. It raised the full-year revenue guidance to $23.50 billion &#8211; $23.60 billion, from $23.30 billion &#8211; $23.55 billion.</li>
<li>Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), General Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>): Boeing CEO Kelly Ortberg skipped the Paris Airshow, while GE delayed its investor day after the deadly Air India crash took the lives of 241 people.</li>
<li>Chime Financial Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHYM#NASDAQ">CHYM</a>): Chime stock closed 37% higher on Thursday following a blockbuster debut on the bourses.</li>
<li>Investors are awaiting earnings results from&nbsp;MoneyHero Ltd.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNY#NASDAQ">MNY</a>) today.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 7.14% to hover around $72.90 per barrel.
Spot prices of gold rose 1.14% to hover around $3,425.35 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was up by 0.33% at the 98.2400 level.
The 10-year Treasury note yield was slightly down by 0.01%.
All of the major Asian markets were in the red on Friday, with the Taiwan Weighted index plunging the most at 0.97%, followed by the Nikkei 225, which fell 0.90%. Similarly, European markets were in the red at the time of writing.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/market-summary/25/06/45918802/middle-east-tensions-rattle-markets-us-stock-futures-slide-oil-jumps-8-gold-surges-above-3400-after-israel-strikes-iran">Middle East Tensions Rattle Markets: US Stock Futures Slide, Oil Jumps 8%, Gold Surges Above $3,400 After Israel Strikes Iran</a></li>
</ul>
Photo courtesy: godongphoto / Shutterstock.com

Equities

ADBE

CHYM

US Stocks Likely To Open Lower As Israel Strikes Iran: Geopolitical Risks Offers Upside For Dollar, Say Experts

TD Securities analyst Andrew Charles reiterates Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) with a Hold and maintains $90 price target.

Price Target

Reiteration

Analyst Ratings

SBUX

TD Securities Reiterates Hold on Starbucks, Maintains $90 Price Target

Earnings

Press Releases

Context Therapeutics Reports Full Year 2024 Operating and Financial Results

Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025

Context Therapeutics to Participate in Upcoming Investor Conferences

Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of CT-95

Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting

Management

Context Therapeutics Announces Chief Medical Officer Transition

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting

Comments

Context Therapeutics

Context Therapeutics (CNTX) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO